We identified Neurocan (NCAN) as one of the top 10 most abundantly expressed proteins (Fig. 1A), which has also been validated as a biomarker for glioblastoma by other groups33, and found to be expressed at low levels in healthy tissue34. This evidence concerns the gene NCAN and glioblastoma.